Answers are grounded in this paper and cite their sources.
Among patients with Gleason score 9-10 prostate cancer, treatment with EBRT+BT with androgen deprivation therapy was associated with significantly better prostate cancer-specific mortality and longer time to distant metastasis compared with EBRT with androgen deprivation therapy or with RP.
No takes yet. Share an insight, caveat, or question.
Kishan et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: